United Kingdom (GB)

Impact of microvascular disease on cardiorenal outcomes in type 2 diabetes: an analysis from the LEADER and SUSTAIN 6 clinical trials (2019) Zinman B, Verma S, Bain SC, Honore JB, Mann J, Nauck MA, Pratley R, et al. Conference contribution Long-term disease stability assessed by the expanded disability status scale in patients treated with Cladribine tablets in the CLARITY and CLARITY extension studies (2019) Giovannoni G, Comi G, Rammohan K, Rieckmann P, Vermersch P, Dangond F, Keller B, Jack D Conference contribution Cd101 is a type 1 diabetes susceptibility gene in NOD mice (2019) Mattner J, Wicker L Conference contribution Macrophage phosphoproteome analysis reveals MINCLE-dependent and -independent mycobacterial cord factor signaling (2019) Hansen M, Peltier J, Killy B, Trost M, Lang R Conference contribution Ultra-fast intramolecular singlet fission to persistent multiexcitons by molecular design (2019) Pun AB, Asadpoordarvish A, Kumarasamy E, Tayebjee MJY, Niesner D, Mccamey DR, Sanders SN, et al. Journal article Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis (2019) Becker M, Graf N, Sauter R, Allanore Y, Curram J, Denton CP, Khanna D, et al. Journal article Therapeutic hypothermia for acute ischaemic stroke. Results of a European multicentre, randomised, phase III clinical trial (2019) Van Der Worp HB, Macleod MR, Bath PMW, Bathula R, Christensen H, Colam B, Cordonnier C, et al. Journal article Tumour mutational burden analysis: implementation in routine diagnostics (2019) Kroeze L, Kamping E, Von Rhein D, Jansen E, De Voer R, Barberis M, Botling J, et al. Conference contribution Homozygous Biallelic KRT5 Mutations in Epidermolysis Bullosa Simplex, Including a Complete Human Keratin 5 "Knock-Out", in Families with Extensive Consanguinity (2019) Vahidnezhad H, Youssefian L, Daneshpazhooh M, Mahmoudi H, Kariminejad A, Fischer J, Christiansen J, et al. Conference contribution Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases (2019) Wollin L, Distler J, Redente EF, Riches DW, Stowasser S, Schlenker-Herceg R, Maher TM, Kolb M Journal article, Review article